Announcements Trials
Browse Landscape

Phase

Phase NA 33Phase 4 2Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Lymphoid 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 2768Triple Negative Breast Neoplasms 406Neoplasm Metastasis 156Breast Neoplasms, Male 102Neoplasms 100Ovarian Neoplasms 69Carcinoma, Non-Small-Cell Lung 68Carcinoma, Intraductal, Noninfiltrating 68Lung Neoplasms 66Brain Neoplasms 60Colorectal Neoplasms 52Inflammatory Breast Neoplasms 50Advanced Breast Cancer 49Breast Carcinoma In Situ 47Prostatic Neoplasms 42Melanoma 38Pancreatic Neoplasms 37Stomach Neoplasms 32Uterine Cervical Neoplasms 28Sarcoma 27HER2-positive Breast Cancer 27Endometrial Neoplasms 25Head and Neck Neoplasms 24Recurrence 23Colonic Neoplasms 22Carcinoma, Renal Cell 21Carcinoma, Ovarian Epithelial 21Small Cell Lung Carcinoma 20Multiple Myeloma 20Carcinoma, Ductal, Breast 20

Interventions

cyclobenzaprine 1Modafinil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Sleep Initiation and Maintenance Disorders × Breast × Clear all
NCT01091974 2017-02-09

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy

University of Rochester

Phase 2 Completed
138 enrolled 10 charts
Breast

Breast Neoplasms, Fatigue, Sleep Initiation and Maintenance Disorders

NCT01921296 2016-04-20

Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients

University of Michigan Rogel Cancer Center

Phase 2 Terminated
2 enrolled 7 charts
Breast

Breast Neoplasms, Sleep Initiation and Maintenance Disorders, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡